Solventum Corp SOLV

Morningstar Rating
$86.40 −2.25 (2.54%)
View Full Chart

Company Report

Price vs Fair Value

SOLV is trading at a LOCK|Xq?@CD premium.
Price
$88.65
Fair Value
p&v
Uncertainty
LOCK|JTH$?
1-Star Price
LOCK|@n
5-Star Price
Q?
Economic Moat
LOCK|<r
Capital Allocation
LOCK|pG?wnY

Bulls Say, Bears Say

Bulls

CEO Bryan Hanson and CFO Wayde McMillan are both highly seasoned leaders with solid records at Covidien, Medtronic, Zimmer Biomet, and Insulet.

Bears

Many of Solventum’s medsurg products are sold to group purchasing organizations, where there is more price pressure than with highly engineered physician preference items marketed directly to doctors.

News

Trading Information

Previous Close Price
$88.65
Day Range
$86.40–88.78
52-Week Range
$62.40–94.08
Bid/Ask
$86.36 / $86.46
Shares Outstanding
169.74M
Market Cap
$14.72B
Volume/Avg
384,134 / 1M

Key Statistics

Price/Earnings (Normalized)
12.55
Price/Sales
1.90
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and infection prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Core
Total Number of Employees
20,000

Competitors

Valuation

Metric
SOLV
COLO B
XRAY
Price/Earnings (Normalized)
12.5536.786.41
Price/Book Value
3.158.051.35
Price/Sales
1.903.970.51
Price/Cash Flow
24.6315.035.83
Price/Earnings
SOLV
COLO B
XRAY

Financial Strength

Metric
SOLV
COLO B
XRAY
Quick Ratio
0.520.410.66
Current Ratio
1.030.741.63
Interest Coverage
1.696.820.02
Quick Ratio
SOLV
COLO B
XRAY

Profitability

Metric
SOLV
COLO B
XRAY
Return on Assets (Normalized)
8.68%11.74%2.67%
Return on Equity (Normalized)
24.95%39.52%10.43%
Return on Invested Capital (Normalized)
14.35%16.18%5.66%
Return on Assets
SOLV
COLO B
XRAY

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
LOCK|%^??nsKLOCK|cq$152B
Becton Dickinson & Co
BDX
LOCK|S>LOCK|#CwK!$59B
Alcon Inc
ALC
LOCK|^<!!Vz!LOCK|Cpbsf$36B
Medline Inc Ordinary Shares - Class A
MDLN
LOCK|x&?Kp&jLOCK|Qt>?$34B
ResMed Inc
RMD
LOCK|%S>Q%&SLOCK|qdt#$34B
West Pharmaceutical Services Inc
WST
LOCK|^<d^jDWLOCK|kt$29B
Baxter International Inc
BAX
LOCK|@%NLOCK|l#H<$13B
The Cooper Companies Inc
COO
LOCK|T%Xp#JkLOCK|rSwp$12B
Align Technology Inc
ALGN
LOCK|jl??nv#LOCK|#y&q#$12B

Sponsor Center